Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 08/31/2020 (updated monthly) $1,376.9 (M)
Net Assets - Advisor ClassAs of 08/31/2020 (updated monthly) $209.1 (M)
P/E Ratio (12-mo Forward)As of 08/31/2020 (updated monthly) 16.58
P/B RatioAs of 08/31/2020 (updated monthly) 6.38

Positions As of 08/31/2020

Portfolio Details

Asset AllocationAs of 08/31/2020

[name] [value]
Equity 94.59%
Cash & Cash Equivalents 5.41%

Geographic BreakdownAs of 08/31/2020

[name] [value]
United States 83.43%
Cash & Cash Equivalents 5.41%
United Kingdom 3.43%
Netherlands 2.81%
Denmark 2.28%
Canada 1.51%
Switzerland 1.13%

sector breakdownAs of 08/31/2020

[name] [value]
Biotechnology 77.69%
Pharmaceuticals 10.97%
Cash & Cash Equivalents 5.41%
Life Sciences Tools & Services 4.57%
Diversified Capital Markets 0.87%
Other Diversified Financial Services 0.28%
Health Care Equipment 0.22%

TOP TEN HOLDINGSAs of 08/31/2020

45.40%
Other
0% 100%
[holdings-table-heading]
REGENERON PHARMACEUTICALS INC 6.91%
VERTEX PHARMACEUTICALS INC 6.82%
AMGEN INC 5.86%
ILLUMINA INC 4.57%
BIOGEN INC 3.95%
IMMUNOMEDICS INC 3.90%
GILEAD SCIENCES INC 3.89%
IOVANCE BIOTHERAPEUTICS INC 3.43%
GW PHARMACEUTICALS PLC 3.18%
NOVAVAX INC 2.89%